Innoviva, Inc.

INVA Nasdaq SEC CIK 1080014
Follow Innoviva Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $106.1M −1.6% vs same quarter last year
Net income −$73.9M −182.2% vs same quarter last year
EPS, diluted −$1.03 −195.4% vs same quarter last year
Operating cash flow $41.7M −16.1% vs same quarter last year
Revenue by quarter
$91.8M
$88.6M
$100.3M
$107.8M
$114.6M
$98M
$119.6M
$106.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$411.3M$271.2M
FY24$358.7M$23.4M
FY23$310.5M$179.7M
FY22$331.3M$220.3M
FY21$391.9M$368.8M
FY20$336.8M$293.8M
FY19$261M$191M
FY18$261M$406.3M
FY17$217.2M$134.3M
FY16$133.6M$59.5M
FY15$53.9M−$18.8M
FY14$8.4M−$168.5M
FY13$4.5M−$170.7M
FY12$5.6M−$18.5M
FY11$24.5M−$115.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−3000%−2000%−1000%0%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2574.8%39.8%65.9%
FY2482.6%46.5%6.5%
FY2379.2%36.7%57.9%
FY22--66.5%
FY21-95.7%94.1%
FY20-95.3%87.2%
FY19-94.4%73.2%
FY18-91.3%155.7%
FY17-84.5%61.8%
FY16-81.6%44.6%
FY15-58.5%−34.8%
FY14-−402.3%−1997.7%
FY13-−635.4%−3766.6%
FY12-−448%−330.3%
FY11-−447.7%−470.6%
Free cash flowOperating cash flow minus capital expenditure
−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$195.8M
FY24$188.4M
FY23$140.7M
FY22$201.7M
FY21$363.8M
FY20$313.1M
FY19$257.4M
FY18$223.5M
FY17$141.7M
FY16$60.7M
FY15$10.1M
FY14−$131.4M
FY13−$132.3M
FY12−$130.1M
FY11−$92M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25-$4.5M
FY24-$14.8M
FY23-$75.7M
FY22-$8.5M
FY21$0$394.1M
FY20$0$0
FY19$11K$0
FY18$80K$0
FY17$281K$97.5M
FY16$960K$78.1M
FY15$87.3M$25.6M
FY14$57M$0
FY13$0$0
FY12$0-
FY11--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Innoviva
  • Healthcare median
−4000%−3000%−2000%−1000%0%1000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearInnovivaHealthcare median
FY2565.9%−30.6%
FY246.5%−47%
FY2357.9%−58%
FY2266.5%−80.4%
FY2194.1%−71.8%
FY2087.2%−62.2%
FY1973.2%−46.2%
FY18155.7%−49.6%
FY1761.8%−45.9%
FY1644.6%−36%
FY15−34.8%−37.8%
FY14−1997.7%−35.5%
FY13−3766.6%−37.1%
FY12−330.3%−29.1%
FY11−470.6%−27.9%